tradingkey.logo

NewGenIvf Group Ltd

NIVF
1.000USD
0.0000.00%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
143.51KMarktkapitalisierung
0.00KGV TTM

NewGenIvf Group Ltd

1.000
0.0000.00%

mehr Informationen über NewGenIvf Group Ltd Unternehmen

NewGenIvf Group Limited is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. It specializes in in-vitro fertilization (IVF) treatment and surrogacy and ancillary caring services. Its fertility treatments, such as IVF, intracytoplasmic sperm injection, intrauterine insemination, egg freezing, embryo transfer, gender selection, semen analysis, hysteroscopy, fertility checkups, testicular sperm aspiration and percutaneous epididymal sperm aspiration. Its clinics are in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions. It has acquired cytometry technology and assets including 18 fully constructed cell-sorting and dispensing systems, eight partially constructed units and six patents related to advanced microfluidic systems.

NewGenIvf Group Ltd Informationen

BörsenkürzelNIVF
Name des UnternehmensNewGenIvf Group Ltd
IPO-datumFeb 15, 2022
CEOWing Fung (Siu)
Anzahl der mitarbeiter76
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 15
Addresse13/F, Ps Tower, Sukhumvit 21 Rd (Asoke)
StadtBANGKOK
BörseNASDAQ OMX - NASDAQ BASIC
LandThailand
Postleitzahl- -
Telefon
Websitehttps://newgenivf.com/
BörsenkürzelNIVF
IPO-datumFeb 15, 2022
CEOWing Fung (Siu)

Führungskräfte von NewGenIvf Group Ltd

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Siu (Alfred) Wing Fung
Mr. Siu (Alfred) Wing Fung
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Fong (Tina) Hei Yue
Ms. Fong (Tina) Hei Yue
Chief Marketing Officer, Director
Chief Marketing Officer, Director
--
--
Mr. Au (Jefferson) Hok Man
Mr. Au (Jefferson) Hok Man
Independent Director
Independent Director
--
--
Ms. Wan Chan Ann Chi
Ms. Wan Chan Ann Chi
Independent Director
Independent Director
--
--
Mr. Wa Tam Chun
Mr. Wa Tam Chun
Independent Director
Independent Director
--
--
Mr. Fai Chung Ho
Mr. Fai Chung Ho
Chief Financial Officer
Chief Financial Officer
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Siu (Alfred) Wing Fung
Mr. Siu (Alfred) Wing Fung
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Fong (Tina) Hei Yue
Ms. Fong (Tina) Hei Yue
Chief Marketing Officer, Director
Chief Marketing Officer, Director
--
--
Mr. Au (Jefferson) Hok Man
Mr. Au (Jefferson) Hok Man
Independent Director
Independent Director
--
--
Ms. Wan Chan Ann Chi
Ms. Wan Chan Ann Chi
Independent Director
Independent Director
--
--
Mr. Wa Tam Chun
Mr. Wa Tam Chun
Independent Director
Independent Director
--
--
Mr. Fai Chung Ho
Mr. Fai Chung Ho
Chief Financial Officer
Chief Financial Officer
--
--

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2024
FY2024Q4
FY2024Q3
FY2023
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
IVF treatment service
5.43M
0.00%
Surrogacy, ancillary caring and other services
0.00
0.00%
Nach RegionUSD
Name
Umsatz
Anteil
Kyrgyzstan
2.66M
48.89%
Thailand
2.18M
40.04%
Cambodia
601.53K
11.07%
HK SAR
0.00
0.00%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
IVF treatment service
5.43M
0.00%
Surrogacy, ancillary caring and other services
0.00
0.00%

Aktionärsstatistik

Aktualisiert: Mon, Feb 2
Aktualisiert: Mon, Feb 2
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
UBS Financial Services, Inc.
0.13%
JAK Opportunities VI LLC
0.10%
Andere
99.77%
Aktionäre
Aktionäre
Anteil
UBS Financial Services, Inc.
0.13%
JAK Opportunities VI LLC
0.10%
Andere
99.77%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
0.14%
Corporation
0.10%
Individual Investor
0.03%
Andere
99.73%

Institutionelle Beteiligung

Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
34
1.53K
0.16%
+1.18K
2025Q3
39
5.79K
0.20%
+1.91K
2025Q2
46
23.90K
1.31%
+20.74K
2025Q1
47
53.83K
2.05%
+29.38K
2024Q4
57
480.38K
3.57%
+160.77K
2024Q3
54
388.28K
4.20%
+63.85K
2024Q2
55
392.14K
4.96%
+40.32K
2024Q1
48
150.75K
80.91%
-221.01K
2023Q4
49
198.33K
101.36%
-231.83K
2023Q3
47
276.28K
99.62%
-143.70K
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
JAK Opportunities VI LLC
2.92K
0.22%
+2.92K
--
Apr 20, 2025
ATW Spac Management LLC
225.00
0.02%
+225.00
--
Oct 04, 2024
White Lion Capital LLC
140.00
0.01%
+140.00
--
Nov 21, 2024
SBI Securities Co., Ltd.
62.00
0%
+62.00
--
Sep 30, 2025
BofA Global Research (US)
2.00
0%
+2.00
--
Sep 30, 2025
RiverNorth Capital Management LLC
--
0%
-18.00
-100.00%
Sep 30, 2024
MMCAP Asset Management
--
0%
-10.00
-100.00%
Jun 30, 2025
Mehr Anzeigen

Verbundene ETFs

Name
Anteil
Keine Daten

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Jan 20, 2026
Merger
3→1
Nov 11, 2025
Merger
5→1
Jul 28, 2025
Merger
5→1
Apr 16, 2025
Merger
10→1
Jan 31, 2025
Merger
20→1
Jan 31, 2025
Merger
20→1
Datum
Ex-Dividendentag
Art
Verhältnis
Jan 20, 2026
Merger
3→1
Nov 11, 2025
Merger
5→1
Jul 28, 2025
Merger
5→1
Apr 16, 2025
Merger
10→1
Jan 31, 2025
Merger
20→1
Jan 31, 2025
Merger
20→1
Jan 31, 2025
Merger
20→1
Jan 31, 2025
Merger
20→1
KeyAI